• Reference Citation Analysis
  • v
  • v
  • Find an Article
Download
Number Select Citation Analysis
1 Xing J, Shankar R, Ko M, Zhang K, Zhang S, Drelich A, Paithankar S, Chekalin E, Chua MS, Rajasekaran S, Kent Tseng CT, Zheng M, Kim S, Chen B. Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants. iScience 2022;25:105068. [PMID: 36093376 DOI: 10.1016/j.isci.2022.105068] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
2 Ince V, Sahin TT, Akbulut S, Yilmaz S. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World J Clin Cases 2022; 10(29): 10413-10427 [DOI: 10.12998/wjcc.v10.i29.10413] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
3 Qi J, Shi Y, Tan Y, Zhang Q, Zhang J, Wang J, Huang C, Ci W. Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways. Clin Epigenetics 2022;14:117. [PMID: 36127710 DOI: 10.1186/s13148-022-01333-4] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
4 Bisht D, Arora A, Sachan M. Role of DNA De-methylation intermediate '5-hydroxymethylcytosine' in ovarian cancer management: A comprehensive review. Biomed Pharmacother 2022;155:113674. [PMID: 36099791 DOI: 10.1016/j.biopha.2022.113674] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
5 Echeverría C, Martin A, Simon F, Salas CO, Nazal M, Varela D, Pérez-castro RA, Santibanez JF, Valdés-valdés RO, Forero-doria O, Echeverría J. In Vivo and in vitro antitumor activity of tomatine in hepatocellular carcinoma. Front Pharmacol 2022;13:1003264. [DOI: 10.3389/fphar.2022.1003264] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
6 Fedyuk V, Erez N, Furth N, Beresh O, Andreishcheva E, Shinde A, Jones D, Zakai BB, Mavor Y, Peretz T, Hubert A, Cohen JE, Salah A, Temper M, Grinshpun A, Maoz M, Zick A, Ron G, Shema E. Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nat Biotechnol 2022. [PMID: 36076083 DOI: 10.1038/s41587-022-01447-3] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
7 Lei B, Song H, Xu F, Wei Q, Wang F, Tan G, Ma H. When does hepatitis B virus meet long-stranded noncoding RNAs? Front Microbiol 2022;13:962186. [DOI: 10.3389/fmicb.2022.962186] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
8 Ahmed YW, Alemu BA, Bekele SA, Gizaw ST, Zerihun MF, Wabalo EK, Teklemariam MD, Mihrete TK, Hanurry EY, Amogne TG, Gebrehiwot AD, Berga TN, Haile EA, Edo DO, Alemu BD. Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing. Clin Epigenetics 2022;14:107. [PMID: 36030244 DOI: 10.1186/s13148-022-01323-6] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
9 Chu J, Bi S, He Y, Ma R, Wan X, Wang Z, Zhang L, Zheng M, Yang Z, Du L, Maimaiti Y, Biekedawulaiti G, Duolikun M, Chen H, Chen L, Li L, Tie L, Lin J. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease. Front Endocrinol (Lausanne) 2022;13:910907. [DOI: 10.3389/fendo.2022.910907] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
10 Truong TTT, Bortolasci CC, Kidnapillai S, Spolding B, Panizzutti B, Liu ZSJ, Kim JH, Dean OM, Richardson MF, Berk M, Walder K. Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs. Int J Mol Sci 2022;23:7508. [DOI: 10.3390/ijms23147508] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
11 Chen R, Wang X, Deng X, Chen L, Liu Z, Li D. CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual’s Disease-Related Signature. Front Pharmacol 2022;13:904909. [DOI: 10.3389/fphar.2022.904909] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
12 Salame N, Fooks K, El-hachem N, Bikorimana J, Mercier FE, Rafei M. Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening. Front Pharmacol 2022;13:852143. [DOI: 10.3389/fphar.2022.852143] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
13 Kim IW, Jang H, Kim JH, Kim MG, Kim S, Oh JM. Retraction Note: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles. Sci Rep 2022;12:9726. [PMID: 35697726 DOI: 10.1038/s41598-022-13460-2] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
14 Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35676420 DOI: 10.1038/s41575-022-00620-y] [Cited by in Crossref: 4] [Cited by in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
15 Lefever DE, Miedel MT, Pei F, DiStefano JK, Debiasio R, Shun TY, Saydmohammed M, Chikina M, Vernetti LA, Soto-Gutierrez A, Monga SP, Bataller R, Behari J, Yechoor VK, Bahar I, Gough A, Stern AM, Taylor DL. A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies. Metabolites 2022;12:528. [PMID: 35736460 DOI: 10.3390/metabo12060528] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
16 Taka N, Asami S, Sakamoto M, Matsui T, Yoshida W. Quantification of Global DNA Hydroxymethylation Level Using UHRF2 SRA-Luciferase Based on Bioluminescence Resonance Energy Transfer. Anal Chem. [DOI: 10.1021/acs.analchem.1c05619] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
17 Vincent F, Nueda A, Lee J, Schenone M, Prunotto M, Mercola M. Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat Rev Drug Discov. [DOI: 10.1038/s41573-022-00472-w] [Cited by in Crossref: 3] [Cited by in RCA: 1] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
18 Ek F, Blom K, Selvin T, Rudfeldt J, Andersson C, Senkowski W, Brechot C, Nygren P, Larsson R, Jarvius M, Fryknäs M. Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma. Sci Rep 2022;12:8943. [PMID: 35624293 DOI: 10.1038/s41598-022-12519-4] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
19 Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O. Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules. J Med Chem 2022. [PMID: 35608571 DOI: 10.1021/acs.jmedchem.2c00281] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
20 Berthelet J, Foroutan M, Bhuva DD, Whitfield HJ, El-saafin F, Cursons J, Serrano A, Merdas M, Lim E, Charafe-jauffret E, Ginestier C, Ernst M, Hollande F, Anderson RL, Pal B, Yeo B, Davis MJ, Merino D. Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin. Cancers (Basel) 2022;14:2404. [DOI: 10.3390/cancers14102404] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
21 Wang Y, Hu X, Long J, Diao J. Epigenetic optical sensing of 5-hydroxymethylcytosine at the single-molecule level. Sens Actuators B Chem 2022;358:131500. [DOI: 10.1016/j.snb.2022.131500] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
22 Roskams-Hieter B, Kim HJ, Anur P, Wagner JT, Callahan R, Spiliotopoulos E, Kirschbaum CW, Civitci F, Spellman PT, Thompson RF, Farsad K, Naugler WE, Ngo TTM. Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies. NPJ Precis Oncol 2022;6:28. [PMID: 35468987 DOI: 10.1038/s41698-022-00270-y] [Cited by in Crossref: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
23 Tang B, Luo H, Xie S, Pan C, Fu J, Wang F. Deubiquitination of TNKS1 Regulates Wnt/β-Catenin to Affect the Expression of USP25 to Promote the Progression of Glioma. Dis Markers 2022;2022:1-8. [PMID: 35450028 DOI: 10.1155/2022/9087190] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
24 Keup C, Kimmig R, Kasimir-bauer S. Combinatorial Power of cfDNA, CTCs and EVs in Oncology. Diagnostics (Basel) 2022;12:870. [DOI: 10.3390/diagnostics12040870] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
25 Li S, Wang Y, Wen C, Zhu M, Wang M, Cao G. Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. Front Cell Dev Biol 2022;10:845641. [DOI: 10.3389/fcell.2022.845641] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
26 Yu M, Yang Y, Sykes M, Wang S. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. J Med Chem 2022. [PMID: 35306814 DOI: 10.1021/acs.jmedchem.1c02139] [Cited by in Crossref: 3] [Cited by in RCA: 1] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
27 Rapicavoli RV, Alaimo S, Ferro A, Pulvirenti A. Computational Methods for Drug Repurposing. Adv Exp Med Biol 2022;1361:119-41. [PMID: 35230686 DOI: 10.1007/978-3-030-91836-1_7] [Cited by in Crossref: 3] [Cited by in RCA: 1] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)]
28 Lu S, Meng Z, Tan Y, Wu C, Huang Z, Huang J, Fu C, Stalin A, Guo S, Liu X, You L, Li X, Zhang J, Zhou W, Zhang X, Wang M, Wu J. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification. BMC Complement Med Ther 2022;22:54. [PMID: 35236335 DOI: 10.1186/s12906-022-03530-3] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
29 Qian X, Yang Z, Gao L, Liu Y, Yan J. The role of complement in the clinical course of hepatocellular carcinoma. Immun Inflamm Dis 2022;10:e569. [PMID: 34813686 DOI: 10.1002/iid3.569] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
30 Besaratinia A, Caceres A, Tommasi S. DNA Hydroxymethylation in Smoking-Associated Cancers. Int J Mol Sci 2022;23:2657. [PMID: 35269796 DOI: 10.3390/ijms23052657] [Cited by in Crossref: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
31 Hsu PJ, Singh K, Dhiman A, Witmer HDD, He C, Eng OS, Catenacci DVT, Posner MC, Turaga KK. Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review. JCO Precis Oncol 2022;6:e2100337. [PMID: 35188804 DOI: 10.1200/PO.21.00337] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
32 Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. β-Catenin signaling in hepatocellular carcinoma. J Clin Invest 2022;132:e154515. [PMID: 35166233 DOI: 10.1172/JCI154515] [Cited by in Crossref: 9] [Cited by in RCA: 7] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
33 Liao CG, Liang XH, Ke Y, Yao L, Liu M, Liu ZK, He L, Guo YX, Bian H, Chen ZN, Kong LM. Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis. Oncogene 2022. [PMID: 35132181 DOI: 10.1038/s41388-022-02213-0] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
34 Hu X, Luo K, Shi H, Yan X, Huang R, Zhao B, Zhang J, Xie D, Zhang W. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer. Clin Epigenetics 2022;14. [DOI: 10.1186/s13148-022-01233-7] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
35 Shtumpf M, Piroeva KV, Agrawal SP, Jacob DR, Teif VB. NucPosDB: a database of nucleosome positioning in vivo and nucleosomics of cell-free DNA. Chromosoma. [DOI: 10.1007/s00412-021-00766-9] [Cited by in Crossref: 3] [Cited by in RCA: 1] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
36 Zhang Z, Lee MK, Perreard L, Kelsey KT, Christensen BC, Salas LA. Navigating the hydroxymethylome: experimental biases and quality control tools for the tandem bisulfite and oxidative bisulfite Illumina microarrays. Epigenomics 2022. [PMID: 35029129 DOI: 10.2217/epi-2021-0490] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
37 Yang JJ, Gessner CR, Duerksen JL, Biber D, Binder JL, Ozturk M, Foote B, Mcentire R, Stirling K, Ding Y, Wild DJ. Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination. BMC Bioinformatics 2022;23. [DOI: 10.1186/s12859-021-04530-9] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
38 Sharma M, Verma RK, Kumar S, Kumar V. Computational challenges in detection of cancer using cell-free DNA methylation. Comput Struct Biotechnol J 2022;20:26-39. [PMID: 34976309 DOI: 10.1016/j.csbj.2021.12.001] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
39 Li Y, Yang C, Liu Z, Du S, Can S, Zhang H, Zhang L, Huang X, Xiao Z, Li X, Fang J, Qin W, Sun C, Wang C, Chen J, Chen H. Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy. Mol Cancer 2022;21:2. [PMID: 34980132 DOI: 10.1186/s12943-021-01462-z] [Cited by in Crossref: 3] [Cited by in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
40 Xu L, Zhou Y, Chen L, Bissessur AS, Chen J, Mao M, Ju S, Chen L, Chen C, Li Z, Zhang X, Chen F, Cao F, Wang L, Wang Q. Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine. Front Cell Dev Biol 2021;9:744990. [PMID: 34957093 DOI: 10.3389/fcell.2021.744990] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
41 Cai X, Zhou J, Deng J, Chen Z. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02413-w] [Cited by in Crossref: 0] [Cited by in RCA: 2] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
42 Faleiro I, Roberto VP, Demirkol Canli S, Fraunhoffer NA, Iovanna J, Gure AO, Link W, Castelo-branco P. DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study. Cancers (Basel) 2021;13:6354. [DOI: 10.3390/cancers13246354] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
43 Fu YH, Tseng CY, Lu JW, Lu WH, Lan PQ, Chen CY, Ou DL, Lin LI. Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis. Biomedicines 2021;9:1869. [PMID: 34944685 DOI: 10.3390/biomedicines9121869] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
44 Xu B, Wang H, Tan L. Dysregulated TET Family Genes and Aberrant 5mC Oxidation in Breast Cancer: Causes and Consequences. Cancers (Basel) 2021;13:6039. [PMID: 34885145 DOI: 10.3390/cancers13236039] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
45 Chen L, Shen Q, Xu S, Yu H, Pei S, Zhang Y, He X, Wang Q, Li D. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34864677 DOI: 10.3233/JAD-215217] [Cited by in Crossref: 7] [Cited by in RCA: 4] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
46 Mair R, Mouliere F. Cell-free DNA technologies for the analysis of brain cancer. Br J Cancer 2021. [PMID: 34811503 DOI: 10.1038/s41416-021-01594-5] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
47 Angeles AK, Janke F, Bauer S, Christopoulos P, Riediger AL, Sültmann H. Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer. Cancers (Basel) 2021;13:5615. [PMID: 34830770 DOI: 10.3390/cancers13225615] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
48 Carvalho RF, do Canto LM, Cury SS, Frøstrup Hansen T, Jensen LH, Rogatto SR. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. Cancers (Basel) 2021;13:5492. [PMID: 34771654 DOI: 10.3390/cancers13215492] [Cited by in Crossref: 0] [Cited by in RCA: 2] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
49 Zhou M, Hou P, Yan C, Chen L, Li K, Wang Y, Zhao J, Su J, Sun J. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers. Clin Epigenetics 2021;13:197. [PMID: 34689838 DOI: 10.1186/s13148-021-01183-6] [Cited by in Crossref: 0] [Cited by in RCA: 1] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
50 Kerachian MA, Azghandi M, Mozaffari-Jovin S, Thierry AR. Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA. Clin Epigenetics 2021;13:193. [PMID: 34663458 DOI: 10.1186/s13148-021-01182-7] [Cited by in Crossref: 0] [Cited by in RCA: 5] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
PrevPage 1 of 7 1234567Next
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA